BHV-7000 Clinical Trials (2026): 9 Studies for Focal Epilepsy & Bipolar Disorder

Where to Participate: All BHV-7000 Trial Sites in the U.S. (47 sites across 23 states)

Every actively recruiting BHV-7000trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

BHV-7000 clinical trials at a glance: phase × recruitment status

Recruiting BHV-7000 clinical trials (3)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

BHV-7000 clinical trials by indication

BHV-7000 pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

Terminated and withdrawn BHV-7000 trials (2)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

• NCT06425159terminatedA Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures
• NCT06423794terminatedBHV-7000 Open-Label Extension Bipolar Mania Study

All BHV-7000 trials (9)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

BHV-7000 clinical trials: frequently asked questions

How many BHV-7000 clinical trials are there?

9 BHV-7000 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 3 are actively recruiting participants. 3 are marked completed.

Are BHV-7000 clinical trials recruiting in 2026?

Yes — 3 BHV-7000 trials are actively recruiting in 2026, with 47 U.S. sites across 23 states. See the recruiting trials and the per-state site list further down this page.

What conditions is BHV-7000 being studied for?

BHV-7000 is being studied for Focal Epilepsy, Bipolar Disorder, Major Depressive Disorder, Familial Erythromelalgia, Generalized Epilepsy. The trials are grouped by indication on this page.

What phase is BHV-7000 in?

BHV-7000 clinical trials span 4 Phase 2, 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors BHV-7000 clinical trials?

The lead sponsor across the most BHV-7000 trials is Biohaven Therapeutics Ltd.. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming BHV-7000as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed August 12, 2026.